These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 37861683)

  • 21. Integration of pre-exposure prophylaxis services into public HIV care clinics in Kenya: a pragmatic stepped-wedge randomised trial.
    Irungu EM; Mugwanya KK; Mugo NR; Bukusi EA; Donnell D; Odoyo J; Wamoni E; Peacock S; Morton JF; Ngure K; Mugambi M; Mukui I; O'Malley G; Baeten JM;
    Lancet Glob Health; 2021 Dec; 9(12):e1730-e1739. PubMed ID: 34798031
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Baseline preferences for oral pre-exposure prophylaxis (PrEP) or dapivirine intravaginal ring for HIV prevention among adolescent girls and young women in South Africa, Uganda and Zimbabwe (MTN-034/IPM-045 study).
    Ngure K; Friedland BA; Szydlo DW; Roberts ST; Garcia M; Levy L; Akello CA; Reddy K; Palanee-Phillips T; Macdonald P; Siziba B; Soto-Torres L; Hosek S; Hillier SL; Nair G; Celum C; van der Straten A
    PLoS One; 2023; 18(6):e0287525. PubMed ID: 37352296
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low selection of HIV PrEP refills at private pharmacies among clients who initiated PrEP at public clinics: findings from a mixed-methods study in Kenya.
    Ortblad KF; Kuo AP; Mogere P; Roche SD; Kiptinness C; Wairimu N; Gakuo S; Baeten JM; Ngure K
    BMC Health Serv Res; 2024 May; 24(1):618. PubMed ID: 38730398
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Providers' Attitudes and Experiences with Pre-Exposure Prophylaxis Implementation in a Population-Based Study in Kenya and Uganda.
    Camlin CS; Getahun M; Koss CA; Owino L; Akatukwasa C; Itiakorit H; Onyango A; Bakanoma R; Atwine F; Maeri I; Ayieko J; Atukunda M; Owaraganise A; Mwangwa F; Sang N; Kabami J; Kaplan RL; Chamie G; Petersen ML; Cohen CR; Bukusi EA; Kamya MR; Havlir DV; Charlebois ED
    AIDS Patient Care STDS; 2022 Oct; 36(10):396-404. PubMed ID: 36201226
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-retroviral Therapy Based HIV Prevention Among a Sample of Men Who Have Sex with Men in Cape Town, South Africa: Use of Post-exposure Prophylaxis and Knowledge on Pre-exposure Prophylaxis.
    Hugo JM; Stall RD; Rebe K; Egan JE; De Swardt G; Struthers H; McIntyre JA
    AIDS Behav; 2016 Dec; 20(Suppl 3):357-364. PubMed ID: 27631366
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High PrEP uptake and objective longitudinal adherence among HIV-exposed women with personal or partner plans for pregnancy in rural Uganda: A cohort study.
    Matthews LT; Atukunda EC; Owembabazi M; Kalyebera KP; Psaros C; Chitneni P; Hendrix CW; Marzinke MA; Anderson PL; Isehunwa OO; Hurwitz KE; Bennett K; Muyindike W; Bangsberg DR; Haberer JE; Marrazzo JM; Bwana MB
    PLoS Med; 2023 Feb; 20(2):e1004088. PubMed ID: 36795763
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Breaking down relationship barriers to increase PrEP uptake and adherence among adolescent girls and young women in Kenya: safety and preliminary effectiveness results from a pilot cluster-randomized trial.
    Roberts ST; Hartmann M; Minnis AM; Otticha SO; Browne EN; Montgomery ET; Agot K
    J Int AIDS Soc; 2023 Dec; 26(12):e26198. PubMed ID: 38123866
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors for loss to follow-up among at-risk HIV negative men who have sex with men participating in a research cohort with access to pre-exposure prophylaxis in coastal Kenya.
    Wahome EW; Graham SM; Thiong'o AN; Mohamed K; Oduor T; Gichuru E; Mwambi J; van der Elst EM; Sanders EJ
    J Int AIDS Soc; 2020 Oct; 23 Suppl 6(Suppl 6):e25593. PubMed ID: 33000889
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adherence, safety, and choice of the monthly dapivirine vaginal ring or oral emtricitabine plus tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis among African adolescent girls and young women: a randomised, open-label, crossover trial.
    Nair G; Celum C; Szydlo D; Brown ER; Akello CA; Nakalega R; Macdonald P; Milan G; Palanee-Phillips T; Reddy K; Tahuringana E; Muhlanga F; Nakabiito C; Bekker LG; Siziba B; Hillier SL; Baeten JM; Garcia M; Johnson S; McClure T; Levy L; Livant E; Jacobson C; Soto-Torres L; van der Straten A; Hosek S; Rooney JF; Steytler J; Bunge K; Parikh U; Hendrix C; Anderson P; Ngure K;
    Lancet HIV; 2023 Dec; 10(12):e779-e789. PubMed ID: 37898146
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preferences for oral PrEP dosing among adolescent boys and young men in three sub-Saharan African countries.
    Kakande A; Ssemata AS; Muhumuza R; Atujuna M; Abaasa A; Ndekezi D; Tshabalala G; Nematadzira T; Hornschuh S; Nomvuyo M; Ahmed N; Maluadzi M; Anne Weiss H; Webb E; Stranix-Chibanda L; Janine Dietrich J; Seeley J; Fox J
    PLoS One; 2023; 18(10):e0285132. PubMed ID: 37812644
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The importance of choice in the rollout of ARV-based prevention to user groups in Kenya and South Africa: a qualitative study.
    Mack N; Evens EM; Tolley EE; Brelsford K; Mackenzie C; Milford C; Smit JA; Kimani J
    J Int AIDS Soc; 2014; 17(3 Suppl 2):19157. PubMed ID: 25224616
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk-based versus universal PrEP delivery during pregnancy: a cluster randomized trial in Western Kenya from 2018 to 2019.
    Kinuthia J; Dettinger JC; Stern J; Ngumbau N; Ochieng B; Gómez L; Abuna F; Watoyi S; Marwa M; Odinga D; Wagner AD; Richardson BA; Pintye J; Baeten JM; John-Stewart G
    J Int AIDS Soc; 2023 Feb; 26(2):e26061. PubMed ID: 36807505
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Integrated provision of topical pre-exposure prophylaxis in routine family planning services in South Africa: a non-inferiority randomized controlled trial.
    Mansoor LE; Yende-Zuma N; Baxter C; Mngadi KT; Dawood H; Gengiah TN; Samsunder N; Schwartz JL; Doncel GF; Abdool Karim Q
    J Int AIDS Soc; 2019 Sep; 22(9):e25381. PubMed ID: 31507088
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Policy considerations for scaling up access to HIV pre-exposure prophylaxis for adolescent girls and young women: Examples from Kenya, South Africa, and Uganda.
    Lane J; Brezak A; Patel P; Verani AR; Benech I; Katz A
    Int J Health Plann Manage; 2021 Sep; 36(5):1789-1808. PubMed ID: 34159630
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pregnancy outcomes and infant growth among babies with in-utero exposure to tenofovir-based preexposure prophylaxis for HIV prevention.
    Heffron R; Mugo N; Hong T; Celum C; Marzinke MA; Ngure K; Asiimwe S; Katabira E; Bukusi EA; Odoyo J; Tindimwebwa E; Bulya N; Baeten JM;
    AIDS; 2018 Jul; 32(12):1707-1713. PubMed ID: 30001244
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhancing HIV pre-exposure prophylaxis outcomes among Kenyan adolescent girls and young women with a novel pharmacy-based PrEP delivery platform: protocol for a cluster-randomized controlled trial.
    Lagat HK; Pintye J; Harrington E; Houck S; Kwena Z; Lenn M; Mogaka F; Momanyi V; Mugambi M; Nyerere B; Odoyo J; Omollo V; Ortblad KF; Rota G; Sharma M; Bukusi EA
    Trials; 2024 Jun; 25(1):394. PubMed ID: 38890744
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact along the HIV pre-exposure prophylaxis "cascade of prevention" in western Kenya: a mathematical modelling study.
    Bershteyn A; Sharma M; Akullian AN; Peebles K; Sarkar S; Braithwaite RS; Mudimu E
    J Int AIDS Soc; 2020 Jun; 23 Suppl 3(Suppl 3):e25527. PubMed ID: 32602669
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Women's preferences for HIV prevention service delivery in pharmacies during pregnancy in Western Kenya: a discrete choice experiment.
    Mugambi ML; Odhiambo BO; Dollah A; Marwa MM; Nyakina J; Kinuthia J; Baeten JM; Weiner BJ; John-Stewart G; Barnabas RV; Hauber B
    J Int AIDS Soc; 2024 Jul; 27 Suppl 1(Suppl 1):e26301. PubMed ID: 38965978
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intimate Partner Violence and Self-Reported Pre-exposure Prophylaxis Interruptions Among HIV-Negative Partners in HIV Serodiscordant Couples in Kenya and Uganda.
    Cabral A; M Baeten J; Ngure K; Velloza J; Odoyo J; E Haberer J; Celum C; Muwonge T; Asiimwe S; Heffron R;
    J Acquir Immune Defic Syndr; 2018 Feb; 77(2):154-159. PubMed ID: 29076883
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Facilitators and barriers to HIV pre-exposure prophylaxis (PrEP) uptake through a community-based intervention strategy among adolescent girls and young women in Seme Sub-County, Kisumu, Kenya.
    Jackson-Gibson M; Ezema AU; Orero W; Were I; Ohiomoba RO; Mbullo PO; Hirschhorn LR
    BMC Public Health; 2021 Jul; 21(1):1284. PubMed ID: 34210288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.